This report studies the global Chronic Obstructive Pulmonary Disorder market, analyzes and researches the Chronic Obstructive Pulmonary Disorder development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Chronic Obstructive Pulmonary Disorder can be split into
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors

Market segment by Application, Chronic Obstructive Pulmonary Disorder can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2022
1 Industry Overview of Chronic Obstructive Pulmonary Disorder
1.1 Chronic Obstructive Pulmonary Disorder Market Overview
1.1.1 Chronic Obstructive Pulmonary Disorder Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Obstructive Pulmonary Disorder Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Obstructive Pulmonary Disorder Market by Type
1.3.1 Short-Acting Bronchodilators
1.3.2 Corticosteroids
1.3.3 Methylxanthines
1.3.4 Long-Acting Bronchodilators
1.3.5 Phosphodiesterase-4 Inhibitors
1.4 Chronic Obstructive Pulmonary Disorder Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies

2 Global Chronic Obstructive Pulmonary Disorder Competition Analysis by Players
2.1 Chronic Obstructive Pulmonary Disorder Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Boehringer Ingelheim
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novartis
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Teva Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Ache Laboratorios Farmaceuticos
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Almirall
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Aquinox Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Ario Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Asmacure
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Astellas Pharma
3.12 BioMarck Pharmaceuticals

4 Global Chronic Obstructive Pulmonary Disorder Market Size by Type and Application (2012-2017)
4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2012-2017)
4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Obstructive Pulmonary Disorder in Future
4.4 Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder

5 United States Chronic Obstructive Pulmonary Disorder Development Status and Outlook
5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
5.2 United States Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

6 EU Chronic Obstructive Pulmonary Disorder Development Status and Outlook
6.1 EU Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
6.2 EU Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

7 Japan Chronic Obstructive Pulmonary Disorder Development Status and Outlook
7.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
7.2 Japan Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

8 China Chronic Obstructive Pulmonary Disorder Development Status and Outlook
8.1 China Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
8.2 China Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

9 India Chronic Obstructive Pulmonary Disorder Development Status and Outlook
9.1 India Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
9.2 India Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Chronic Obstructive Pulmonary Disorder Development Status and Outlook
10.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
10.2 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)

12 Chronic Obstructive Pulmonary Disorder Market Dynamics
12.1 Chronic Obstructive Pulmonary Disorder Market Opportunities
12.2 Chronic Obstructive Pulmonary Disorder Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Obstructive Pulmonary Disorder Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Obstructive Pulmonary Disorder Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source




List of Tables and Figures

Figure Chronic Obstructive Pulmonary Disorder Product Scope
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2017)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Type in 2016
Figure Short-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Methylxanthines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Long-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Phosphodiesterase-4 Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Teva Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Teva Pharmaceuticals (2012-2017)
Figure Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ache Laboratorios Farmaceuticos (2012-2017)
Figure Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Almirall Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Almirall (2012-2017)
Figure Almirall Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Aquinox Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Aquinox Pharmaceuticals (2012-2017)
Figure Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ario Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ario Pharma (2012-2017)
Figure Ario Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Asmacure Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Asmacure (2012-2017)
Figure Asmacure Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table BioMarck Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of BioMarck Pharmaceuticals (2012-2017)
Figure BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2022
Figure United States Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2022
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2022

Mood Disorder Monitoring Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Mood Disorder Monitoring Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Chronic Disease Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Chronic Disease Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...

Chronic Disease Data Management Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Chronic Disease Data Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...

Advanced Chronic Care Management Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Advanced Chronic Care Management Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Global Autism Spectrum Disorder Screening Service Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Autism Spectrum Disorder Screening Service Market: The report discusses everything a marketer requires before investing in the global Autism Spectrum Disorder Screening Service Market during t...

Global Circadian Rhythm Seep Disorder Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Circadian Rhythm Seep Disorder Market: The report discusses everything a marketer requires before investing in the global Circadian Rhythm Seep Disorder Market during the forecast period 2023-...

Global Sleep Disorder Management Software Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Sleep Disorder Management Software Market: The report discusses everything a marketer requires before investing in the global Sleep Disorder Management Software Market during the forecast peri...

Global Vitamin B3-B4 Market (2023 Edition): Analysis By Vitamin Type (Vitamin B3, Vitamin B4), Formulation (Dry, Liquid), By Application, By Region, By Country: Market Insights and Forecast (2018-2028)...

Executive Summary Azoth Analytics has released a research report titled "Vitamin B3-B4 Market (2023 Edition)" which provides a complete analysis of the global Vitamin B3-B4 industry in terms of market segmentation Vitamin Type (Vitamin B3, Vitamin B4), By Formulation (Dry, Liquid), By A...

Global In-Office Sleep Disorder Treatments Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global In-Office Sleep Disorder Treatments Market: The report discusses everything a marketer requires before investing in the global In-Office Sleep Disorder Treatments Market during the forecast pe...

Global Post-Traumatic Stress Disorder (PTSD) Medications Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Post-Traumatic Stress Disorder (PTSD) Medications: The report discusses everything a marketer requires before investing in the global Post-Traumatic Stress Disorder (PTSD) Medications during t...